These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29225252)

  • 21. Hemophagocytic lymphohistiocytosis after allogeneic bone marrow transplantation during chronic norovirus infection.
    Salvador C; Meister B; Larcher H; Crazzolara R; Kropshofer G
    Hematol Oncol; 2014 Jun; 32(2):102-6. PubMed ID: 23922241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications.
    Kawamura Y; Miura H; Matsumoto Y; Uchida H; Kudo K; Hata T; Ito Y; Kimura H; Yoshikawa T
    BMC Pediatr; 2016 Oct; 16(1):172. PubMed ID: 27793118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemophagocytic syndrome associated with Epstein-Barr virus. Presentation of a case and treatment in the Resuscitation Unit].
    Figueiredo González O; Iglesias Fernández M; Río Gómez A; Ulibarrena Redondo C; Casas García ML
    Rev Esp Anestesiol Reanim; 2014 Dec; 61(10):571-4. PubMed ID: 24468010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of antithymocyte globulin for allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis.
    Arai Y; Jo T; Matsui H; Kondo T; Takaori-Kondo A
    Leuk Lymphoma; 2017 Aug; 58(8):1840-1848. PubMed ID: 27951736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infusion of leukocytes from HLA haplo-identical familial donors as an adjuvant in the HLH-2004 protocol to treat the virus-associated adult hemophagocytic lymphohistiocytosis: a retrospective study of 26 patients.
    Zhang H; Dai Z; Yang N; Wang J; He A; Wang J; Zhang Y; Meng S; Wang B; Sun R; Zhang W
    Ann Hematol; 2018 Feb; 97(2):319-326. PubMed ID: 29130133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infectious complications associated with alemtuzumab use for allogeneic hematopoietic stem cell transplantation: comparison with anti-thymocyte globulin.
    Park SH; Choi SM; Lee DG; Choi JH; Yoo JH; Kim SH; Kim HJ; Cho SG; Eom KS; Lee JW; Min WS; Shin WS; Kim CC
    Transpl Infect Dis; 2009 Oct; 11(5):413-23. PubMed ID: 19708893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous Renal Replacement Therapy with oXiris® Membrane in Severe Ebstein-Barr Virus-Mediated Hemophagocytic Lymphohistiocytosis: A Case Report.
    Samman KN; Baalbaki H; Bouchard J; Albert M
    Blood Purif; 2021; 50(4-5):578-581. PubMed ID: 33333505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential transplants for respective relapse of Hodgkin disease and hemophagocytic lymphohistiocytosis: a treatment dilemma.
    Chang YH; Lu PJ; Lu MY; Wang JS; Tung CL; Shaw CF
    J Pediatr Hematol Oncol; 2009 Oct; 31(10):778-81. PubMed ID: 19755921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled Epstein-Barr virus reactivation after allogeneic transplantation is associated with improved survival.
    Auger S; Orsini M; Céballos P; Fegueux N; Kanouni T; Caumes B; Klein B; Villalba M; Rossi JF
    Eur J Haematol; 2014; 92(5):421-8. PubMed ID: 24400833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of rare co-occurrence of Epstein-Barr virus-driven post-transplant lymphoproliferative disorder and hemophagocytic lymphohistiocytosis after allogeneic stem cell transplantation.
    Weber T; Wickenhauser C; Monecke A; Gläser C; Stadler M; Desole M; Ligeti K; Behrmann C; Müller-Tidow C; Müller LP
    Transpl Infect Dis; 2014 Dec; 16(6):988-92. PubMed ID: 25179757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of five cases of hepatitis associated aplastic anemia presenting with hemophagocytic lymphohistiocytosis at onset].
    Wei A; Ma HH; Zhang LP; Wu RH; Zhang R; Wang TY
    Zhonghua Er Ke Za Zhi; 2020 Mar; 58(3):213-217. PubMed ID: 32135593
    [No Abstract]   [Full Text] [Related]  

  • 32. Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation.
    Peric Z; Cahu X; Chevallier P; Brissot E; Malard F; Guillaume T; Delaunay J; Ayari S; Dubruille V; Le Gouill S; Mahe B; Gastinne T; Blin N; Saulquin B; Harousseau JL; Moreau P; Milpied N; Coste-Burel M; Imbert-Marcille BM; Mohty M
    Leukemia; 2011 Jun; 25(6):932-8. PubMed ID: 21350556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A comparative study on early toxicity of conditioning regimen with or without antithymocyte globulin].
    Liu DH; Liu J; Liu KY; Xu LP; Chen H; Chen YH; Han W; Wang Y; Zhang XH; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Aug; 30(8):519-23. PubMed ID: 19954638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful salvage treatment with antithymocyte globulin for patients with early-onset hemophagocytic lymphohistiocytosis refractory to steroid and etoposide therapy following allogeneic hematopoietic stem cell transplantation.
    Kakinoki Y; Ishio T; Kimura H; Shimono J; Miyashita N; Sekine T; Kasahara K
    Bone Marrow Transplant; 2020 Jul; 55(7):1479-1482. PubMed ID: 31992843
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful Treatment of Veno-occlusive Disease, Transplantation-Associated Thrombotic Microangiopathy, and Acute Graft-vs-Host Disease in a Patient with Relapsed Epstein-Barr Hemophagocytic Lymphohistiocytosis After Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report.
    Zhang C; Tan X; Yao H; Liu Y; Gao L; Gao L; Kong PY; Zhang X
    Transplant Proc; 2019 Nov; 51(9):3159-3162. PubMed ID: 31711585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fatal exacerbations of chronic active Epstein-Barr virus infection subsequent to cytotoxic chemotherapy].
    Suma S; Kurita N; Baba N; Ishitsuka K; Sukegawa S; Makishima K; Kiyoki Y; Maruyama Y; Kato T; Yokoyama Y; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Chiba S
    Rinsho Ketsueki; 2019; 60(4):286-290. PubMed ID: 31068557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary Epstein-Barr virus infection and probable parvovirus B19 reactivation resulting in fulminant hepatitis and fulfilling five of eight criteria for hemophagocytic lymphohistiocytosis.
    Karrasch M; Felber J; Keller PM; Kletta C; Egerer R; Bohnert J; Hermann B; Pfister W; Theis B; Petersen I; Stallmach A; Baier M
    Int J Infect Dis; 2014 Nov; 28():143-6. PubMed ID: 25242697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does anti-thymocyte globulin have a place in busulfan/fludarabine conditioning for matched related donor hematopoietic stem cell transplantation?
    Ji YS; Lee MS; Min CW; Park SK; Kim SH; Yun J; Kim HJ; Kim KH; Kim CK; Lee KT; Won JH; Hong DS
    Korean J Intern Med; 2016 Jul; 31(4):750-61. PubMed ID: 27017944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and Outcomes of Central Nervous System Hemophagocytic Lymphohistiocytosis Relapse after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation.
    Lounder DT; Khandelwal P; Chandra S; Jordan MB; Kumar AR; Grimley MS; Davies SM; Bleesing JJ; Marsh RA
    Biol Blood Marrow Transplant; 2017 May; 23(5):857-860. PubMed ID: 28219834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk for complications in patients with hemophagocytic lymphohistiocytosis who undergo hematopoietic stem cell transplantation: myeloablative versus reduced-intensity conditioning regimens.
    Schechter T; Naqvi A; Weitzman S
    Expert Rev Clin Immunol; 2014 Aug; 10(8):1101-6. PubMed ID: 24871821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.